1. Home
  2. CNXN vs FTRE Comparison

CNXN vs FTRE Comparison

Compare CNXN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNXN

PC Connection Inc.

HOLD

Current Price

$58.55

Market Cap

1.6B

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.38

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXN
FTRE
Founded
1982
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CNXN
FTRE
Price
$58.55
$17.38
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$15.56
AVG Volume (30 Days)
80.6K
1.3M
Earning Date
02-04-2026
11-05-2025
Dividend Yield
1.03%
N/A
EPS Growth
N/A
N/A
EPS
3.24
N/A
Revenue
$2,878,704,000.00
$2,759,900,000.00
Revenue This Year
$5.85
$3.17
Revenue Next Year
$4.52
$0.11
P/E Ratio
$18.02
N/A
Revenue Growth
3.19
1.88
52 Week Low
$54.97
$3.97
52 Week High
$74.84
$19.53

Technical Indicators

Market Signals
Indicator
CNXN
FTRE
Relative Strength Index (RSI) 46.78 66.77
Support Level $56.53 $16.91
Resistance Level $58.95 $18.26
Average True Range (ATR) 1.25 0.89
MACD -0.11 -0.18
Stochastic Oscillator 44.93 56.62

Price Performance

Historical Comparison
CNXN
FTRE

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: